Treatment outcomes of low-level viremia among adults living with HIV on dolutegravir-based first line antiretroviral therapy in Botswana

被引：0
|
作者：
Bareng, Ontlametse T. [1 ,2 ]
Moyo, Sikhulile [1 ,3 ]
Mudanga, Mbatshi [4 ]
Sebina, Kagiso [4 ]
Koofhethile, Catherine [1 ,3 ]
Choga, Wonderful [1 ,2 ]
Gobe, Irene [2 ]
Motswaledi, Modisa [2 ]
Maruapula, Docas [1 ]
Moraka, Natasha [1 ,2 ]
Musonda, Rosemary [1 ]
Nkomo, Joseph [5 ]
Ramaabya, Dinah [5 ]
Chebani, Tony [5 ]
Makuruetsa, Penny [5 ]
Makhema, Joseph [1 ,3 ]
Gaseitsiwe, Simani [1 ,3 ]
机构：
[1] Botswana Harvard Aids Inst, Gaborone, Botswana
[2] Univ Botswana, Fac Allied Hlth Profess, Dept Med Sci, Gaborone, Botswana
[3] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
[4] BUMMHI, Gaborone, Botswana
[5] Minist Hlth, Gaborone, Botswana
来源：
BMJ GLOBAL HEALTH | 2023年 / 8卷 / SUPPL_10期
关键词：
D O I：
10.1136/bmjgh-2023-EDC.53
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
OA-770
引用
收藏
页码：A24 / A24
页数：1
相关论文
共 50 条
  • [21] Cardiovascular Profile of South African Adults with Low-Level Viremia during Antiretroviral Therapy
    Botha-Le Roux, Shani
    Elvstam, Olof
    De Boever, Patrick
    Goswami, Nandu
    Magnusson, Martin
    Nilsson, Peter M.
    Strijdom, Hans
    Bjorkman, Per
    Fourie, Carla M. T.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (10)
  • [22] Antiretroviral Drug Resistance in HIV-1-Infected Patients Experiencing Persistent Low-Level Viremia During First-Line Therapy
    Taiwo, Babafemi
    Gallien, Sebastien
    Aga, Evgenia
    Ribaudo, Heather
    Haubrich, Richard
    Kuritzkes, Daniel R.
    Eron, Joseph J., Jr.
    JOURNAL OF INFECTIOUS DISEASES, 2011, 204 (04): : 515 - 520
  • [23] Impact of low-level viremia with drug resistance on CD4 cell counts among people living with HIV on antiretroviral treatment in China
    Pengtao Liu
    Yinghui You
    Lingjie Liao
    Yi Feng
    Yiming Shao
    Hui Xing
    Guanghua Lan
    Jianjun Li
    Yuhua Ruan
    Dan Li
    BMC Infectious Diseases, 22
  • [24] Impact of low-level viremia with drug resistance on CD4 cell counts among people living with HIV on antiretroviral treatment in China
    Liu, Pengtao
    You, Yinghui
    Liao, Lingjie
    Feng, Yi
    Shao, Yiming
    Xing, Hui
    Lan, Guanghua
    Li, Jianjun
    Ruan, Yuhua
    Li, Dan
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [25] Clinical Outcomes After Viremia Among People Receiving Dolutegravir vs Efavirenz-Based First-line Antiretroviral Therapy in South Africa
    Asare, Kwabena
    Lewis, Lara
    van der Molen, Johan
    Sookrajh, Yukteshwar
    Khubone, Thokozani
    Moodley, Pravikrishnen
    Lessells, Richard J.
    Naidoo, Kogieleum
    Sosibo, Phelelani
    Garrett, Nigel
    Dorward, Jienchi
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (12):
  • [26] Viral suppression among adults with HIV receiving routine dolutegravir-based antiretroviral therapy and 3 months weekly isoniazid-rifapentine
    Chaisson, Lelia H.
    Semitala, Fred C.
    Nangobi, Florence
    Steinmetz, Samantha
    Marquez, Carina
    Armstrong, Derek T.
    Opira, Bishop
    Kamya, Moses R.
    Phillips, Patrick P. J.
    Dowdy, David W.
    Yoon, Christina
    AIDS, 2023, 37 (07) : 1097 - 1101
  • [27] Four-class drug-resistant HIV-1 subtype C in a treatment experienced individual on dolutegravir-based antiretroviral therapy in Botswana
    Seatla, Kaelo K.
    Avalos, Ava
    Moyo, Sikhulile
    Mine, Madisa
    Diphoko, Thabo
    Mosepele, Mosepele
    Gaolatlhe, Tendani
    Rowley, Christopher F.
    Ramaabya, Dinah
    Jarvis, Joseph N.
    Kasvosve, Ishmael
    Gaseitsiwe, Simani
    AIDS, 2018, 32 (13) : 1899 - 1902
  • [28] Incidence of low-level viremia and its impact on virologic failure among people living with HIV-1 who switched to elvitegravir-based antiretroviral therapy
    Hsu, Jen-Yu
    Sun, Hsin-Yun
    Hsieh, Tan-Wen
    Chang, Sui-Yuan
    Chuang, Yu-Chung
    Huang, Yu-Shan
    Hsiao, Ching-Yu
    Su, Yi-Ching
    Liu, Wen-Chun
    Chang, Shu-Fang
    Hung, Chien-Ching
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2022, 29 : 7 - 16
  • [29] Prevalence of and Factors Associated with Hypertension Among Adults on Dolutegravir-Based Antiretroviral Therapy in Uganda: A Cross Sectional Study
    Mutebi, Ronald Kasoma
    Semulimi, Andrew Weil
    Mukisa, John
    Namusobya, Martha
    Namirembe, Joy Christine
    Nalugga, Esther Alice
    Batte, Charles
    Mukunya, David
    Kirenga, Bruce
    Kalyesubula, Robert
    Byakika-Kibwika, Pauline
    INTEGRATED BLOOD PRESSURE CONTROL, 2023, 16 : 11 - 21
  • [30] HIV Drug Resistance Profile in Clients Experiencing Treatment Failure After the Transition to a Dolutegravir-Based First-Line Antiretroviral Treatment Regimen in Mozambique
    Ismael, Nalia
    Hussein, Cidia
    Magul, Cacildo
    Inguane, Humberto
    Couto, Aleny
    Nhangave, Amancio
    Muteerwa, Ana
    Bonou, Mahoudo
    Ramos, Artur
    Young, Peter Wesley
    Chilundo, Sonia
    Machekano, Rhoderick
    Greenberg, Lauren
    da Silva, Juliana
    Bhatt, Nilesh
    PATHOGENS, 2025, 14 (01):
12345